A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

新泽西州罗斯兰 - 市值1.01亿美元的先进药物输送仪器开发商Milestone Scientific Inc. (NYSE: MLSS)宣布在领先的疼痛管理诊所Advanced Spine and Pain Management商业推出其CompuFlo®硬膜外麻醉系统。这一进展是在与Varinder ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...